These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24293115)

  • 1. A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy.
    Rose BI
    J Assist Reprod Genet; 2014 Feb; 31(2):195-8. PubMed ID: 24293115
    [No Abstract]   [Full Text] [Related]  

  • 2. Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?
    Lainas GT; Lainas TG; Sfontouris IA; Chatzimeletiou K; Venetis CA; Bosdou JK; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Sep; 34(9):1770-1777. PubMed ID: 31384921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro oocyte maturation: current status.
    Nogueira D; Sadeu JC; Montagut J
    Semin Reprod Med; 2012 Jun; 30(3):199-213. PubMed ID: 22585631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro maturation (IVM) of human oocytes.
    Strowitzki T
    Arch Gynecol Obstet; 2013 Nov; 288(5):971-5. PubMed ID: 24068296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparision of in vitro maturation applied in PCOS and non-PCOS patients undergo stimulated and unstimulated protocols].
    Wang P; Zhao J; Jin C; Yu R; Lin J; Zhu R; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):903-8. PubMed ID: 25608990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turn, turn, turn.
    Evers JL
    Hum Reprod; 2013 Sep; 28(9):2313-4. PubMed ID: 23887074
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors for ovarian hyperstimulation syndrome: relevance of the number of follicles, serum estradiol levels and the number of oocytes collected.
    Ata B; Seyhan A; Polat M; Young Son W; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2595. PubMed ID: 23838158
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro maturation--a potential approach of infertility treatment of patients with PCOS].
    Kostov I; Ingilizova G
    Akush Ginekol (Sofiia); 2013; 52(4):25-8. PubMed ID: 24283075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose hCG supplementation after GnRH agonist triggering: Don't be too quick on the trigger.
    Bodri D
    Hum Reprod; 2013 Sep; 28(9):2315-7. PubMed ID: 23633554
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro maturation of oocytes: uncommon indications.
    Grynberg M; El Hachem H; de Bantel A; Benard J; le Parco S; Fanchin R
    Fertil Steril; 2013 Apr; 99(5):1182-8. PubMed ID: 23380185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation.
    Huang JY; Chian RC; Tan SL
    Semin Reprod Med; 2010 Nov; 28(6):519-31. PubMed ID: 21157982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery and maturation of immature oocytes in patients at risk for ovarian hyperstimulation syndrome.
    Coskun S; Jaroudi KA; Hollanders JM; Atared AM; Roca GL
    J Assist Reprod Genet; 1998 Jul; 15(6):372-7. PubMed ID: 9673881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human oocyte maturation in vitro.
    Coticchio G; Dal-Canto M; Guglielmo MC; Mignini-Renzini M; Fadini R
    Int J Dev Biol; 2012; 56(10-12):909-18. PubMed ID: 23417413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Embryonic Development and Clinical Outcomes between In vitro Oocytes Maturation Using Micro-Vibration System and In vivo Oocytes Maturation in Polycystic Ovarian Syndrome Patients.
    Yang SH; Hur YS; Yoon SH; Jung JH; Lim JH; Ko Y
    Gynecol Obstet Invest; 2020; 85(3):252-258. PubMed ID: 32268326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome.
    Gustofson RL; Segars JH; Larsen FW
    Hum Reprod; 2006 Nov; 21(11):2830-7. PubMed ID: 16966348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS.
    Son WY; Yoon SH; Lim JH
    Reprod Biomed Online; 2006 Sep; 13(3):340-8. PubMed ID: 16984762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.